Viewing Study NCT04824794

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 1:47 AM
Ignite Modification Date: 2026-02-09 @ 1:40 AM
Study NCT ID: NCT04824794
Status: TERMINATED
Last Update Posted: 2025-12-22
First Post: 2021-03-09
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: GEN3014 Trial in Relapsed or Refractory Hematologic Malignancies
Sponsor: Genmab
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Relapsed or Refractory Multiple Myeloma (RRMM) View
None Diffuse Large B Cell Lymphoma (DLBCL) View
None Acute Myeloid Leukemia (AML) View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Hexabody® View
None Anti-CD38 View
None monoclonal antibody View